Study Summary
This trial is testing a new drug to see if it is safe and effective for treating adults with spinocerebellar ataxia, a degenerative neurological disorder.
- Spinocerebellar Ataxia Type 3
Treatment Effectiveness
Effectiveness Progress
Study Objectives
1 Primary · 5 Secondary · Reporting Duration: 4, 13, 26, 39, and 52 weeks
Trial Safety
Safety Progress
Trial Design
4 Treatment Groups
SLS-005 0.75 g/kg Dose
1 of 4
SLS-005 0.50 g/kg Dose
1 of 4
Placebo volume equivalent to a SLS-005 0.75 g/kg dose calculation
1 of 4
Placebo volume equivalent to a SLS-005 0.50 g/kg dose calculation
1 of 4
Experimental Treatment
Non-Treatment Group
245 Total Participants · 4 Treatment Groups
Primary Treatment: SLS-005 · Has Placebo Group · Phase 2 & 3
Trial Logistics
Trial Timeline
Who is running the clinical trial?
Eligibility Criteria
Age 18 - 75 · All Participants · 9 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:Who else is applying?
What state do they live in?
| California | 100.0% |
How old are they?
| 18 - 65 | 100.0% |
What site did they apply to?
| University of South Florida | 100.0% |
What portion of applicants met pre-screening criteria?
| Did not meet criteria | 66.7% |
| Met criteria | 33.3% |
How responsive is this trial?
Typically responds via
| Phone Call | 50.0% |
| 50.0% | |
Most responsive sites:
- University of South Florida: < 48 hours
Average response time
- < 2 Days
Frequently Asked Questions
What is the highest number of people who can enroll in this research project?
"Yes, this is an ongoing trial that is still recruiting patients, as of October 11th, 2022. The trial was first posted on June 3rd, 2022 and is looking for 245 patients total, at 7 different sites." - Anonymous Online Contributor
Are individuals who are over the age of 30 allowed to participate in this research project?
"This particular clinical trial requires that applicants are aged 18 to 75. While there are 19 clinical trials for patients that are younger and 33 for patients that are older, this is the only study with these age requirements." - Anonymous Online Contributor
Are there any specific patients this study is designed for?
"The researchers conducting this trial are looking for 245 individuals that have spinocerebellar ataxia type 3 and are between 18-75 years old. The applicants must also meet the following requirements: Be able to provide informed consent, be of either gender, have a BMI between 18-35 kg/m2, have been taking the same doses of medication for the past 30 days, have a negative pregnancy test for female participants of childbearing potential, and be willing to comply with sexual abstinence or contraception guidelines." - Anonymous Online Contributor
Are participants being sought for this experiment currently?
"That is correct, the online information specifies that the clinical trial is looking for enrollees. The trial was first posted on June 3rd, 2022 and was last updated on October 11th, 2022. There is a need for 245 patients at 7 sites." - Anonymous Online Contributor